Zevra Therapeutics (ZVRA) Treasury Shares (2021 - 2025)
Historic Treasury Shares for Zevra Therapeutics (ZVRA) over the last 5 years, with Q3 2025 value amounting to $11.0 million.
- Zevra Therapeutics' Treasury Shares changed 0.0% to $11.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $11.0 million for FY2024, which is 0.0% changed from last year.
- As of Q4 2024, Zevra Therapeutics' Treasury Shares stood at $1.8 million, which was up 17612.29% from $665739.0 recorded in Q4 2023.
- Over the past 5 years, Zevra Therapeutics' Treasury Shares peaked at $1.8 million during Q4 2024, and registered a low of $320161.0 during Q4 2021.
- In the last 4 years, Zevra Therapeutics' Treasury Shares had a median value of $787846.0 in 2022 and averaged $964077.1.
- In the last 5 years, Zevra Therapeutics' Treasury Shares soared by 16780.38% in 2022 and then changed by 0.0% in 2024.
- Zevra Therapeutics' Treasury Shares (Quarter) stood at $2.8 million in 2021, then soared by 167.8% to $7.5 million in 2022, then soared by 45.74% to $11.0 million in 2023, then changed by 0.0% to $11.0 million in 2024, then changed by 0.0% to $11.0 million in 2025.
- Its last three reported values are $11.0 million in Q3 2025, $11.0 million for Q2 2025, and $11.0 million during Q1 2025.